Effect of iberdomide on cutaneous manifestations in systemic lupus erythematosus: a randomized phase 2 clinical trial - SUPPLEMENTARY MATERIAL
Published: 19 September 2024| Version 1 | DOI: 10.17632/pfsydwvcj2.1
Contributors:
Victoria P. Werth, Joan T. Merrill, Richard Furie, Thomas Dörner, Ronald van Vollenhoven, Peter Lipsky, Michael Weiswasser, Shimon Korish, Peter H. Schafer, Mark Stern, Stan Li, Nikolay DelevDescription
Supplementary materials for the Effect of iberdomide on cutaneous manifestations in systemic lupus erythematosus: a randomized phase 2 clinical trial manuscript.
Files
Institutions
Bristol-Myers Squibb
Categories
Systemic Lupus Erythematosus, Lupus Erythematosus
Funding
Bristol-Myers Squibb